TABLE 1.
Cell types | Models | Diseases | Findings | Refs |
---|---|---|---|---|
Microglia | Bmal1 deficiency | Asthma | Decrease pro‐inflammatory cytokines and increase anti‐inflammatory cytokines in microglial BV2 cells following LPS stimulation | 75 |
Macrophages | Rev‐erbα deficiency | Rheumatoid arthritis | Abolish the circadian rhythmicity of IL‐6 in LPS‐induced macrophages and endotoxin‐treated mice | 74 |
Macrophages | Jet lag | Melanoma | Induce the loss or inversion of daily patterns of M1 and M2 macrophages and cytokine levels | 73 |
Microglia | Clock deficiency | Glioblastoma | Decrease intratumoral microglia infiltration in the tumor microenvironment and increase overall survival | 76 |
Neutrophils | Rev‐erbα deficiency | Hepatic I/R | Aggravate hepatic I/R injury and significantly increases the number of neutrophils infiltrated to I/R liver | 155 |
Neutrophils | Bmal1 deficiency | IBD | Abolish daily variations in granule contents and NETs formation | 89 |
NK cells | Per1 deficiency | Lung cancer | Disrupt and alter the rhythmic levels of perforin, granzyme B, and IFN‐γ released by splenic NK cells | 112 |
NK cells | Chronic shift‐lag | Autoimmune disease | Accelerate the aging process of NK cells, characterized by reduced expression of Ly49 and impaired release of granular CD107a and IFN‐γ | 113 |
NK cells | Per2 deficiency | Non‐small cell lung cancer | Confer greater resistance to LPS‐induced endotoxic shock, which could be attributed to decreased production of IFN‐γ/IL‐1β and suppression of NK cell function | 156 |
NK cells | Bmal1 deficiency | IBD | Reduce ILC3s counts in the small intestine and increase the frequency of ILC3s in the mesenteric lymph nodes | 23 |
ILCs | Rev‐erbα deficiency | IBD | Reduce the cell numbers of NKp46+ ILC3 subset, RORγt expression, and IL‐22 production, whereas increase IL‐17 secretion paradoxically | 116 |
ILCs | Bmal1 deficiency | IBD | Decrease in the population of ILC3 within the small intestine of mice | 115 |
DCs | Clock deficiency | Autoimmune inflammation | Diminish the capacity for TH17‐cell differentiation and reduce TH17‐cell frequencies in the gut | 102 |
T cells | Clock deficiency | B‐cell lymphoma | Impair B‐cell development and lead to a significant reduction in B‐cell populations in peripheral blood, spleen, and bone marrow | 107 |
B cells | Bmal1 deficiency | Lymphomas | Disrupt the oscillation of B‐cell numbers in lymph nodes | 101 |
Abbreviations: Bmal1, Brain and Muscle ARNT‐Like 1; Clock, circadian locomotor output cycles kaput; DCs, dendritic cells; I/R, ischemia/reperfusion; IBD, inflammatory bowel disease; IFN‐γ, interferon‐γ; IL, interleukin; ILC3s, Group 3 innate lymphoid cells; LPS, lipopolysaccharides; NETs, neutrophil extracellular traps; NK, natural killer; Per1, period 1; Per2, period 2; Rev‐erbα, nuclear reverse erythroblastosis virus heme receptor α; RORγt, retinoic acid receptor‐related orphan receptor γt; TH17, T helper 17.